MitraClip (TEER) Procedure – Minimally Invasive Treatment for Mitral Valve Regurgitation
Restore Heart Function Without Open-Heart Surgery
MitraClip, also known as Transcatheter Edge-to-Edge Repair (TEER), is a minimally invasive heart valve procedure designed to treat mitral valve regurgitation (MR) – a condition where blood leaks backward through the mitral valve due to improper closure.
This catheter-based mitral valve repair allows doctors to fix the valve without open-heart surgery. It is especially beneficial for high-risk or elderly patients who are not suitable for traditional valve surgery.
Mitral regurgitation can lead to:
MitraClip is recommended when:
🕒 Procedure Time: 1–3 hours
🏥 Hospital Stay: 1–2 days
⏱️ Recovery Time: 3–7 days
Benefit | Advantage for Patients |
No open-heart surgery | Ideal for high-risk or elderly patients |
Short recovery time | Back to daily life in under a week |
Reduced hospitalizations | Especially for heart failure patients |
Immediate symptom relief | Less shortness of breath and fatigue |
FDA- and CE-approved device | Clinically proven for safety and results |
Like any heart procedure, MitraClip has potential risks:
Your cardiology team will assess all risks and provide safe, personalized care.
MitraClip is recommended for:
Many international patients are choosing MitraClip heart valve treatment abroad for:
Your MitraClip procedure abroad may include:
(Pricing may vary depending on hospital, patient health, and location)
Interested in minimally invasive mitral valve repair without open surgery?
📱 Call / WhatsApp: [+91 93553 93131]
📧 Email: [Info@broadhealthnetwork.com]
🌐 Website: [https://broadhealthnetwork.com/]
Get a personalized treatment plan
Transparent pricing and expert advice
Start your journey to better heart health
Broad Health Network : Revolutionizing global healthcare with advanced telemedicine, AI diagnostics, remote patient monitoring, and seamless medical data sharing worldwide.